DENVER--(BUSINESS WIRE)--EvoEndo ®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), is pleased to share recent decisions announced by the ...
Society High-grade dysplasia Low-grade dysplasia No dysplasia Ref. American Gastroenterological Association Definitive treatment EMR/ablation or surveillance every 3 months Repeat EGD in 6 months. If ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback